華興資本:重申平安好醫生(1833.HK) “買入”評級
格隆匯7月29日丨華興資本發佈了中國互聯網醫療的行業報告,覆蓋平安好醫生(1833.HK)並將公司歸為建議關注標的。該行表示,看到中國互聯網醫療行業的兩個主要發展領域:互聯網+藥品和互聯網+醫療服務。自2018年以來,隨着中國出台了更多的監管政策,該行業變得更加規範,故華興資本對行業前景持樂觀態度,給予平安好醫生“買入”評級,目標價128.72港元。華興資本指出,2014年,平安好醫生等平台開始提供在線諮詢,然後逐漸擴展其服務範圍。該行認為平安好醫生是在線諮詢行業的早期代表,能在行業早期於醫療健康參與者和互聯網領域的投資者之間建立高度的合作伙伴關係。由於最初的在線諮詢吸引了其他服務的訪問量,因此公司將其主要業務擴展到了在線諮詢、消費者保健、健康購物中心和健康管理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.